Summary Doxorubicin (DXR) has a positive inoculum effect and penetrates poorly into the core of multicellular tumour spheroids (MTS). Cis-platin (DDP) displays neither of these characteristics. We evaluated whether combining these 2 agents would influence the cell kill effect at a tumour mass level. MTS were produced from a PC-10 squamous lung carcinoma cell line. MTS were exposed to either drug first for h with different intervals between exposure. Cells were then trypsinized to a single cell suspension and subjected to clonogenic assay. Combination effects were analyzed by median effect plot analysis. The more MTS ml-' medium, the lower the cell kill effect of DXR. Simultaneous exposure to the 2 drugs was synergistic. DXR exposure first followed by DDP was less efficacious than, or the same as, the simultaneous exposure. In contrast, DDP followed by DXR was more efficacious with the best cell kill at a 1 h interval between each drug. This phenomenon was observed even at non-toxic doses of DDP. The fluorescent microscopic study of DXR indicated that prior exposure of MTS to DDP resulted in increased DXR penetration into the MTS core leading to heightened synergism with this sequence. These data suggest that the proper combination of DXR plus DDP should be in sequence with DDP first. Clinical, toxicological and pharmacological trials of DDP administration first, followed by DXR, are warranted.
Doxorubicin (DXR) and cis-platin (DDP) are both highly active anticancer agents widely used in the treatment of human cancer. We introduced a combination of these 2 agents, termed A & P (adriamycin and platinum) (Vogl et al., 1976) , which has become the basis, by adding more drugs, for the treatment of patients with ovarian cancer, small cell lung cancer and other neoplasms. Recently, we have demonstrated that DXR has a positive inoculum effect in vitro and loses efficacy at high cell densities, whereas DDP does not (Ohnuma et al., 1986) . Moreover, we have shown that DXR penetrates poorly into the core of multicellular tumour spheroids (MTS) whereas DDP shows no such penetration gradient (Inoue et al., 1985) . These pharmacological differences at the tumour mass level indicate that DXR should be best used when tumour size is small and cell density low. Therefore, we hypothesized that the proper sequence of A & P should be DDP first, followed by DXR, rather than vice versa. This communication sets forth the experimental proof of our hypothesis and elucidates a possible mechanism for this effect.
Materials and methods
Human tumour cell line PC-10 squamous lung carcinoma cell line was used in these experiments (Kinjo et al., 1979) . Cells were maintained as a monolayer in RPMI-1640 medium (GIBCO, Grand Island, NY) , supplemented with 10% (v/v) heat-inactivated foetal bovine serum (FBS) (Gibco) at 37"C in a 5% CO2/95% humidified air atmosphere. These cells were subcultured after trypsinization with 0.2% trypsin (Type III from bovine pancreas, Sigma, St Louis, MD) and 0.01% EDTA in Hank's balanced salt solution (HBSS) (Gibco).
Growth of MTS MTS were developed by a liquid overlay culture technique (Yuhas et al., 1977) , as described previously (Kohno et al., 1987 (Kuroki, 1974 (Chou & Talalay, 1984 Chou, 1985 
where (Dx)1 and (Dx)2 are the doses of drugs 1 and 2, respectively, required to produce x00 effect individually.
(Dx) 1 and (Dx)2 for x% cell kill can be determined by drawing a least square regression line on the computer graphic system. (D)1 and(D)2 are the doses of drugs 1 and 2, respectively, which are required to produce the same x% effect in combination. If the drugs are mutually exclusive, then a is 0: if mutually non-exclusive, then a is 1. When CI = 1, the interaction was considered additive; when CI< 1, synergism was indicated; and when CI> 1, antagonism was indicated.
Fluorescent microscopy MTS of -700,m diam. were treated with 2 x 10 M of DXR alone or combination of DXR and 2 x 10-I M DDP at 1 h intervals of each drug, which was the best cell kill sequence. The treated MTS were washed with ice-cold PBS once, embedded in OCT compound (Miles Scientific, IL) and frozen rapidly. Thin sections (5 gm) were made using a cryotome (Lipshaw Elect, MI). DXR fluorescence was observed under a fluorescent microscope equipped with epiillumination (Nikon, DS-EPI-FL, Japan) using G-Green (excitation filter 535-550 jgm, barrier filter 580 gm). In this system endogenous fluorescence from control MTS (ones not exposed to DXR) could not be recognized.
Results
The influence of MTS density on DXR-or DDP-induced cell lethality is shown in Figure 1 . For DXR-induced cell lethality, the higher the density of MTS, the lesser the cell kill effects and dose-response curves of DXR progressively flattened at high drug concentrations. In contrast, DDP gave entirely different dose-effect curves; cell survival curves for high MTS density and low density overlapped each other and there was progressively increasing cell kill at increasing doses.
Time dependent cell lethality of the combination of DXR plus DDP at low MTS density is illustrated in Figure 2 .
Three lines are shown for 3 different concentrations of the drug. DXR exposure followed by DDP was less efficacious than, or the same as, simultaneous exposure. In contrast, exposure to DDP followed by DXR was more efficacious; the best cell kill with a 1 h interval between each drug. Increasing time intervals from DDP to DXR for longer than 1 h resulted in a gradual diminution of the potentiation.
The influence of MTS density on time-dependent cell lethality of DXR plus DDP combination is shown in Figure   C Time of administration of doxorubicin (h) Figure 2 Time-dependent cell lethality of doxorubicin plus cisplatin on multicellular tumour spheriods. Three different concentrations of doxorubicin and cis-platin tested are shown on the right side of each line. Bar, s.d. 3. The differences of the 2 lines on the left half of the panel indicate weak activity of the combination at high MTS density when DXR is administered first. When the 2 drugs were given simultaneously, the survival fractions were nearly identical, indicative of better expression of DDP activity. For both low and high MTS densities, the best cell kill sequence of this combination was DDP followed by DXR with a 1 h interval between the 2 drugs. When the interval between DDP followed by DXR widened, the 2 lines began to separate again, suggesting the same effect of MTS density seen when DXR was given first.
Examples of the median effect plot analysis from the combination-DXR followed 24h later by DDP, simultaneous exposure of the 2 drugs and DDP followed 1 h later by DXR -are shown in Figure 4 . All of these 3 lines showed synergistic interactions; among them, the DDP expo- Pretreatment with low concentrations of DDP, which was non-toxic to cells in monolayer, also produced increased DXR-induced cell kill: I x 10-7 M DDP produced a decrease in surviving fraction up to 30% for cells in MTS (Table I) . These results indicate that DXR penetration was enhanced by non-toxic concentrations of cis-platin and that the penetration-enhancing effects can be separable from the cytotoxic effects of the compound.
Fluorescent microscopic observations of DXR penetration into MTS are illustrated in Figure 5 . When MTS were exposed to DXR alone, DXR fluorescence was seen in only a few outerlayer(s) of the MTS. When MTS were exposed to DDP I h previously -the best cell kill sequence -DXR fluorescence was seen within the entire layers of the MTS ( Figure 5, Panel b) .
Discussion
MTS have certain characteristics similar to de novo solid tumours (Allison et al., 1983; Franko & Sutherland, 1979; Freyer & Sutherland, 1980; Sutherland & Durant, 1973; Yuhas et al., 1977 Yuhas et al., ,1978 . They contain such extracellular matrix as fibronectin, laminin and collagen (Nederman & Twentyman, 1984) , comprise a chronically hypoxic cell population in the core (Franko & Sutherland, 1979; Sutherland & Durant, 1973) and show heterogenous cell cycle times (Allison et al., 1983; Freyer & Sutherland, 1980) . For these reasons, MTS have been used as an in vitro model to study the effects of radiation (Allison et al., 1983; Franko & Sutherland, 1979; Freyer & Sutherland, 1980; Sasaki et al., 1984a; Sutherland & Durant, 1973) and chemotherapeutic agents (Erlichman & Vidgen, 1984; Kerr et al., 1986; Nederman & Twentyman, 1984; Sasaki et al., 1984b; West et al., 1980) . Our data show that the density of MTS influences the cell kill effect of certain drugs. The higher the density of MTS, the lesser the cell kill effect of DXR. The concept of inoculum effect seen at a single cell level could thus be extended to the density of MTS. Since solid tumour masses in vitro do not grow more than 300-400pm in diameter without a blood supply (Folkman, 1986; Kolstad, 1968) II-, n have assumed that a large clinically recognizable tumour mass with neovasculature is equivalent to MTS in high density. The DDP-induced cell kill effect seemed to follow first order kinetics irrespective of MTS density, indicating good drug penetration into the MTS core. In contrast, the cell kill effect of DXR was progressively less efficacious at higher drug concentrations as a consequence of poor drug penetration.
The combination study herein presented shows that sequencing DDP and DXR influenced the cell kill effect at a tumour mass level. As seen in Figure 4 , DDP plus DXR was always synergistic, with the exception of very low concentrations of the drugs. With increasing effect levels the combination index was progressively lower indicating heightened synergism. The drug sequencing studies showed that the best cell kill sequence was DDP first with a 1 h interval before DXR exposure. The increased synergistic interaction of this sequence was shown to be due to an increased population of cells in MTS at risk.
In attempts to elucidate the mechanism of the heightened cell kill effect from this sequence, we evaluated whether DDP could influence cell lethality and penetration of DXR. Pretreatment of DDP increased DXR-induced cell lethality even at non-toxic low concentration levels for MTS. This was not observed for monolayers. For fluorescent microscopy study, DXR concentrations of .2 x 10-5 M were necessary in order to detect the fluorescence. Exposure to DXR alone resulted in DXR fluorescence only on one or two outer layer(s) of the MTS (Inoue et al., 1985) . When MTS were exposed to DDP and DXR in this sequence, DXR fluorescence was seen throughout the MTS, indicating good penetration of DXR. The precise mechanism of DDPinduced improvement in DXR penetration is unclear. Other workers indicated that drug penetration into MTS is influenced by (a) cell to cell interaction in MTS, (b) molecular size of the drug, (c) liquid solubility of the drug and (d) intraspheroidal pH gradients (Erlichman & Vidgen, 1984; Kerr et al., 1986) . It is likely that DDP exposure changed cell-to-cell interactions within the MTS, making it easier for DXR to penetrate into the core. While the interaction between DDP and cell membrane is poorly understood, it has been observed that the compound binds with cell surface DNA, leading to the loss of the nucleic acid (Juckett & Rosenberg, 1982) . Erlichman and Vidgen (1984) reported that avid binding of DXR to the outer layer of MTS inhibited penetration of the drug into the core. It is possible that the avid binding of DXR to cell surface material such as DNA was inhibited by pretreatment with DDP.
Theoretical and practical aspects of combination chemotherapy at a single cell level have been discussed by Sartorelli and Creasey (1982) . Little information has so far been provided, however, on the approach with combination chemotherapy at the tumour mass level. Sensitivity of a cell to DXR and DDP is known to be highly related to the intracellular drug concentration (Eichholtz-Wirth & Hietel, 1986; Iliakis & Lazor, 1987) . Any means to increase the drug penetration into MTS should improve drug concentration within the cells in the MTS core.
Our observations indicate that initial treatment with DDP resulted in increased efficacy for DXR at the tumour mass level. Clinical, toxicological and pharmacological trials of DDP followed by DXR are warranted.
